|
2024
|
P/S
|
Radiopharmaceutical drug delivery agent in the form of an intracellular and nuclear enhancer; rad... |
|
2023
|
Invention
|
Covalently-modified steroid acid-peptides having enhanced stability and/or biological activity. S... |
|
|
Invention
|
Covalently-modified steroid acid-peptides having enhanced stability and/or biological activity |
|
|
Invention
|
Steroid acid-peptide based cytotoxic compounds.
Agents having cytotoxic activity, as well as com... |
|
|
P/S
|
Drug delivery agent in the form of an intracellular enhancer in the nature of compounds that faci... |
|
|
P/S
|
Drug delivery agent in the form of an intracellular enhancer; medicinal preparations for use in o... |
|
|
P/S
|
Drug delivery agents consisting of intracellular enhancers in the nature of compounds that facili... |
|
|
P/S
|
Vaccines for human use; medicinal preparations for use in oncology; drug delivery agent consistin... |
|
|
Invention
|
Conjugates enhancing total cellular accumulation. The present description relates to a conjugated... |
|
|
Invention
|
Steroid acid-based immunogen enhancers. Immunogen enhancers for admixture with an antigen of inte... |
|
2022
|
Invention
|
Steroid acid-peptide based intracellular cargo delivery.
Described herein are compositions and m... |
|
|
Invention
|
Steroid acid-peptide based intracellular cargo delivery. Described herein are compositions and me... |
|
|
Invention
|
Steroid acid-peptide based cytotoxic compounds. Agents having cytotoxic activity, as well as comp... |
|
|
Invention
|
Conjugates enhancing total cellular accumulation.
The present description relates to a conjugate... |
|
|
Invention
|
Steroid acid-based hydrogels.
Steroid acid-based hydrogels and methods of production thereof are... |
|
|
Invention
|
Steroid acid-based hydrogels. Steroid acid-based hydrogels and methods of production thereof are ... |
|
|
P/S
|
Vaccines for human use; medicinal preparations for use in
oncology; drug delivery agent in the f... |
|
|
P/S
|
VACCINES FOR HUMAN USE; MEDICINAL PREPARATIONS FOR USE IN ONCOLOGY; DRUG DELIVERY AGENT CONSISTIN... |
|
|
Invention
|
Covalently modified antigens for improved immune response and/or stability. Covalently modified p... |
|
|
P/S
|
Vaccines for human use; medicinal preparations for use in oncology; drug delivery agent in the fo... |
|
|
P/S
|
Drug delivery agent in the form of an intracellular
enhancer. |
|
2021
|
P/S
|
Drug delivery agent in the form of an intracellular enhancer |
|
|
P/S
|
Research and development of vaccines and medicines |
|
|
P/S
|
Vaccines for human use; medicinal preparations for use in oncology Research and development of v... |
